Brinker Capital Investments’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
Other funds holding FOLD
PA
ACA
RG
PAI
Brinker Capital Investments's FOLD Position: Q1 2025 in Review
Brinker Capital Investments sold out of Amicus Therapeutics (FOLD) in Q1 2025, closing a stake of 84,693 shares — an estimated $798K sold.
Brinker Capital Investments first reported a position in FOLD in Q1 2021 and held it in 16 quarters. The position peaked at $2.01M in Q4 2022. 286 funds tracked by Wall St. Rank hold FOLD as of Q1 2025.
- Brinker Capital Investments reported no remaining Amicus Therapeutics position as of Q1 2025 after selling out during the quarter.
- Brinker Capital Investments sold 84,693 Amicus Therapeutics shares in Q1 2025, an estimated $798K.
- Brinker Capital Investments first reported a position in Amicus Therapeutics in Q1 2021 and held it in 16 quarters.
- Brinker Capital Investments's Amicus Therapeutics position peaked at $2.01M in Q4 2022.
- 286 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2025.
Based on Brinker Capital Investments's 13F filing for Q1 2025, filed 1 Aug 2025.